Skip to main content
Top

Diabetology International

Issue 1/2011

Content (5 Articles)

Review article

Roles of autophagy in pancreatic β-cell function and type 2 diabetes

Yoshio Fujitani, Toyoyoshi Uchida, Koji Komiya, Hiroko Abe, Ryuzo Kawamori, Hirotaka Watada

Original article

Prognostic importance of home blood pressure measurement in patients with diabetic nephropathy

M. Nishimura, M. Kato, F. Shimada, Y. Kato, R. Todo, Y. Ando, K. Hida, I. Iseda, A. Tone, N. Nagase, H. Yoshizumi, K. Higashi, Y. Hoshiyama

Original article

Higher level of serum vascular endothelial growth factor in type 2 diabetic patients with diabetic retinopathy hospitalized for hyperglycemic state

Yoshihiro Takamiya, Yoichi Oikawa, Hiroshi Hirose, Akira Shimada, Hiroshi Itoh

Original article

Assessment of plasma glucose cutoff values to predict the development of type 2 diabetes in a Japanese sample: the Funagata Study

Toshihide Oizumi, Makoto Daimon, Shigeru Karasawa, Wataru Kaino, Kaoru Takase, Yumi Jimbu, Kiriko Wada, Wataru Kameda, Shinji Susa, Takeo Kato

Original article

Addition of sitagliptin to ongoing glimepiride therapy in Japanese patients with type 2 diabetes over 52 weeks leads to improved glycemic control

Naoko Tajima, Takashi Kadowaki, Masato Odawara, Mikio Nishii, Tadaaki Taniguchi, Juan Camilo Arjona Ferreira

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.